Introduction
Dematiaceous fungi are being increasingly recogMaterials and methods nized as human pathogens [1] particularly in Exophiala spinifera, one Exophiala dermatitidis, one Correspondence: Dr J. Meletiadis, Department of Medical Exophiala castellanii) were evaluated in this study.
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The isolates were frozen in glycerol at −70°C 9101, 6500 HB Nijmegen, The Netherlands. before they were tested. As quality controls Candida free control. For amphotericin B only, the MIC at a concentration of 3200 mg ml−1 in dimethyl was determined as the lowest concentration showsulphoxide (DMSO), terbinafine was dissolved first ing 100% visible growth inhibition. For isolates in DMSO with 5% Tween 80 followed by adding with MICs outside scale, the lowest and the highest the same volume of DMSO so that the final drug concentration, respectively, were considered. concentration of terbinafine was 1600 mg ml−1, itraconazole was dissolved at a concentration of 3200 mg ml−1 in 0.2 M HCl/acetone (50%/50%),
Data analysis voriconazole was dissolved at a concentration of
The ranges and geometric means of MICs as well 3200 mg ml−1 in water with 10% dimethylformamas the MIC 90 and MIC 50 were determined for ide and amphotericin B was dissolved at a conceneach drug. tration of 5000 mg l−1 in sterile water. Each drug was serially twofold diluted in RPMI 1640 to obtain two times the final concentration which ranged from 64 to 0.06 mg ml−1 for miconazole, Results 32 to 0.03 mg ml−1 for terbinafine, itraconazole, UR 9825 and voriconazole and 16 to
The growth for most of the isolates was adequate at 48 h and for all after 72 h. The MIC range, 0.015 mg ml−1 for amphotericin B. The first concentration of itraconazole was made in water and geometric means, MIC 90 and MIC 50 for the isolates of E. spinifera after 48 h and 72 h incubation not in RPMI 1640 in contrast with the other dilutions of drugs. Therefore wells 1-11 contained are summarized in Table 1 . All the isolates of E. spinifera were very susceptible to the six drugs that a series of drug dilutions in 100 ml volumes. Well 12 contained drug-free medium and served as the were used since the MICs 90 for all drugs were lower than 1 mg ml−1. The isolates were less susgrowth control. The microtitre plates were kept at −70°C.
ceptible for miconazole with MICs after 72 h ranging from 0.125 to 1 mg ml−1 and a geometric mean of 0.46 mg ml−1 and for amphotericin B Medium with MICs ranging from 0.125 to 1 mg ml−1 and a geometric mean of 0.37 mg ml−1. The most The medium used was liquid RPMI 1640 (GIBCO BRL, Life Technologies, The Netherlands) with active drug was terbinafine with a geometric mean of 0.06 mg l−1 and the MIC 90 of 0.125 mg ml−1 and l-glutamine without sodium bicarbonate and supplemented with 0.165 m MOPS buffer. The pH of voriconazole with a geometric mean of 0.08 mg l−1 and MIC 90 of 0.25 mg ml−1. the medium was adjusted to 7.0±0.1 at 22°C.
The antifungal activities of the six drugs against the two isolates of E. dermatitidis and E. castellanii Inoculum preparation are shown in Table 2 . Both isolates were very susceptible to the six drugs with MICs lower than Each isolate had been grown for 7 days on Sabouraud glucose agar with 0.5% chloramphen-0.5 mg ml−1. The most active drug was terbinafine whose MICs were 0.03 mg ml−1 for both isolates. icol at room temperature and was then subcultured mycoses 43, 309-312 (2000) The present results show that clinical isolates of Exophiala are susceptible to all the antifungal drugs treated with surgical excision combined with antimycotic treatment [2, 3] . There is however, no that were evaluated. Interestingly, terbinafine appeared to be very active in vitro against Exophiala standard therapy and the responses to different treatment regimens were variable. Response to species. Clinical experience with terbinafine in the treatment of patients with phaeohyphomycosis or treatment appears to depend on the time of diagnosis. One patient with an early diagnosis chromoblastomycosis is limited. In an open trial treatment of chromoblastomycosis with terbinafine responded to surgical excision alone [13] whereas others have died because the diagnosis was not at a dosage of 500 mg day−1 resulted in a spectacular improvement of lesions [18] . Moreover, cure made during life [14] .
Several drug regimens have been used for the was observed in imidazole-refractory patients or chronic cases [18] . Terbinafine appeared to be treatment of infections by Exophiala species including amphotericin B in combination with ketoconainactive in an experimental model in which mice were challenged with three agents of central zole, ketoconazole, itraconazole combined with 5-flucytosine [15] , and itraconazole monotherapy.
nervous system phaeohyphomycosis namely Cladophialophora bantiana, Ochroconis constricta and One patient failed to treatment with ketoconazole but responded to oral itraconazole [16] . Some Exophiala dermatitidis [19] . However, terbinafine is metabolized very rapidly in rodents and low drug authors consider itraconazole to be the drug of choice for the treatment of patients with phaeohylevels may account for the poor efficacy. Nevertheless, terbinafine may be a promising agent phomycosis [17] . However, in one patient with chromoblastomycosis caused by E. spinifera the since the drug achieves excellent levels in the skin. Moreover, the drug may be synergistic when lesions progressed during therapy with itraconazole, and this was associated with a rise of the combined with azoles. Terbinafine acts within the
